Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2003
11/06/2003US20030206941 Fast dissolving orally consumable films
11/06/2003US20030206898 Use of anti-TNFalpha antibodies and another drug
11/06/2003US20030206869 Delivery of antidepressants through an inhalation route
11/06/2003US20030206861 Uses of diterpenoid triepoxides as an antiproliferative agent
11/06/2003US20030206857 Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
11/06/2003CA2484546A1 Methods and compositions for treatment of cancer pain
11/06/2003CA2484089A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
11/06/2003CA2484067A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003CA2483515A1 Novel thiol derivative, method for producing the same and use thereof
11/06/2003CA2483505A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003CA2483500A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003CA2483431A1 Alternatively spliced nucleic acid molecules
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483306A1 Pyrazolo[1,5-a]pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
11/06/2003CA2483265A1 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/06/2003CA2483253A1 Use of compounds having ccr antagonism
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003CA2483102A1 Treatment and prevention of pulmonary conditions
11/06/2003CA2483091A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo' b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003CA2483075A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003CA2483072A1 Cannabinoids
11/06/2003CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480497A1 Substituted pyrazine derivatives
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/06/2003CA2480092A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/05/2003EP1358883A1 Re-epithelializing pharmaceutical compositions containing xanthan gum
11/05/2003EP1358878A1 Remedies/preventives for inflammatory diseases
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358212A1 Methods for the synthesis of a modified hemoglobin solution
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1358188A2 Antagonists of mcp-1 function and methods of use thereof
11/05/2003EP1358187A2 Naphthyridine derivatives
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358182A1 Diazocine derivatives and their use as tryptase inhibitors
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358156A2 Benz(g) indoles and their use as spla2 inhibitors
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1357937A2 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1357910A2 Method for preventing and treating visceral pain and gastrointestinal disorders
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1090020B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0839039B1 Paroxetine controlled release compositions
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0656061B1 Novel glycoforms of soluble complement receptor 1
11/05/2003EP0652874B1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/05/2003EP0601106B2 Morphogen-induced modulation of inflammatory response
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453010A Liniment for treating rheumarthritis and similar diseases and its prepn
11/05/2003CN1452994A Multifunctional paster
11/05/2003CN1452989A Medicated wine for treating rheumatism and rheumatoid disease
11/05/2003CN1452983A Delayed-releasing compound diclofenac sodium prepn
11/05/2003CN1452980A Pain-relieving and inflammation-diminishing medicine composition and its production process
11/05/2003CN1452979A Medicine composition with anti-inflammatory effect and its production process
11/05/2003CN1452974A Globeflower powder for injection and its prepn
11/05/2003CN1126737C Novel pyrrole compound, its preparation and pharmaceutical composition containing the same
11/05/2003CN1126556C Lumbago plaster
11/05/2003CN1126535C Aqueous suspension for nasal administration of loteprednol
11/04/2003US6642386 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642257 Agents for treating neuropathic pain
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642241 Alkylamino- substituted dihydropyrimido-(4,5-d)pyrimidinone derivatives, inhibitors of p38,
11/04/2003US6642240 Treating emesis in a mammal
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642225 Diazacycloalkanedione derivatives
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003US6642210 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
11/04/2003US6642201 Use of a dipeptide for stimulating repair processes
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641820 Treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to target
11/04/2003US6641806 Inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, nonbovine proteoglycan such as
1 ... 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 ... 1272